Clinical Trial: A Single and Multiple Ascending Dose Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP6590 in Participants With Normal Weight, Overweight and Obesity

U.S., July 24 -- ClinicalTrials.gov registry received information related to the study (NCT07721597) titled 'A Single and Multiple Ascending Dose Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP6590 in Participants With Normal Weight, Overweight and Obesity' on July 16.

Brief Summary: The goal of this clinical trial is to learn about the safety and tolerability of drug ZP6590 and to learn how the body processes the drug ZP6590 in adults. The main questions it aims to answer are:

* Is the drug ZP6590 safe and well tolerated when administered as escalating single and multiple doses of the ZP6590?

* How quickly and to what extent the administered investigational drug is absorbed and distributed, and how long...